I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Amivantamab plus lazertinib in osimertinib-relapsed EGFR -m..:
Cho, Byoung Chul
;
Kim, Dong-Wan
;
Spira, Alexander I
...
Nature Medicine, Vol.29 No.10, pp.2577-2585. , 2023
Link:
https://hdl.handle.net/10371/195815
RT Journal T1
Amivantamab plus lazertinib in osimertinib-relapsed EGFR -mutant advanced non-small cell lung cancer: a phase 1 trial
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_195815&Exemplar=1&LAN=DE A1 Cho, Byoung Chul A1 Kim, Dong-Wan A1 Spira, Alexander I A1 Gomez, Jorge E A1 Haura, Eric B A1 Kim, Sang-We A1 Sanborn, Rachel E A1 Cho, Eun Kyung A1 Lee, Ki Hyeong A1 Minchom, Anna A1 Lee, Jong-Seok A1 Han, Ji-Youn A1 Nagasaka, Misako A1 Sabari, Joshua K A1 Ou, Sai-Hong Ignatius A1 Lorenzini, Patricia A1 Bauml, Joshua M A1 Curtin, Joshua C A1 Roshak, Amy A1 Gao, Grace A1 Xie, John A1 Thayu, Meena A1 Knoblauch, Roland E A1 Park, Keunchil PB Nature Publishing Group YR 2023 K1 TYROSINE KINASE INHIBITORS K1 ANTIBODY TARGETING EGFR K1 BISPECIFIC ANTIBODY K1 OPEN-LABEL K1 PROTEIN EXPRESSION K1 1ST-LINE TREATMENT K1 CHEMOTHERAPY K1 RESISTANCE K1 NSCLC K1 MULTICENTER JF Nature Medicine, Vol.29 No.10, pp.2577-2585 LK http://dx.doi.org/https://hdl.handle.net/10371/195815 DO https://hdl.handle.net/10371/195815 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)